Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUET-2: Etravirine in Treatment-Experienced HIV-1
NCT00255099Phase 3Completed
- Sponsor
- Tibotec
- Start
- Dec 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of etravirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Tibotec. Started Dec 2005; status: completed.
02
Drugs
etravirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00255099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00255099.